Medical research

Predicting disease emergence from forest fragmentation

A Massey University team has developed new ways of predicting disease-hot spots, created by humans changing the environment, to help identify where and how society can mitigate the risk of infectious disease emergence, such ...

Diseases, Conditions, Syndromes

Modified malaria drug proven effective at inhibiting Ebola

Robert Davey, professor of microbiology at Boston University School of Medicine and researcher at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), in collaboration with researchers at Nagasaki ...

Diseases, Conditions, Syndromes

Texas Biomed scientists researching Ebola-malaria connection

Ebola virus is a continuing threat in Central and West Africa, with an outbreak currently taking place in the Democratic Republic of Congo. The disease kills up to 90% of the people who get infected, and more than 150 people ...

Diseases, Conditions, Syndromes

DRC may provide model for containing future Ebola outbreaks

When the Ebola virus struck West Africa in 2014, it resisted early attempts at control. It took more than two years to overcome, claiming more than 11,000 lives. Volunteers from the West who were infected were flown home ...

Diseases, Conditions, Syndromes

Experts highlight Ebola vaccine progress and suggest next steps

Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium. In a Viewpoint ...

Immunology

Team finds potent antibodies against three Ebola viruses

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

Diseases, Conditions, Syndromes

Broadly acting antibodies found in plasma of Ebola survivors

Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

page 7 from 28